In addition, cytokines such as CCL5 and CXCL10 may promote cancer cell proliferation by recruiting myeloid cells, and this is essential to activate the immune checkpoint PD-1/PD-L1 axis, which establishes an immunosuppressive tumor microenvironment in multiple cancer types [47–50]. The gene discussed is CCL5; the disease is cancer.